Cargando…

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection

Glioblastomas (GBs) are the most aggressive form of primary brain cancer and virtually incurable. Accumulation of regulatory T (T reg) cells in GBs is thought to contribute to the dampening of antitumor immunity. Using a syngeneic mouse model for GB, we tested whether local delivery of cytokines cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	vom Berg, Johannes, Vrohlings, Melissa, Haller, Sergio, Haimovici, Aladin, Kulig, Paulina, Sledzinska, Anna, Weller, Michael, Becher, Burkhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2013
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865478/ https://www.ncbi.nlm.nih.gov/pubmed/24277150 http://dx.doi.org/10.1084/jem.20130678

Ejemplares similares

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28
por: Lin, Hua, et al.
Publicado: (1998)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
por: Waitz, Rebecca, et al.
Publicado: (2012)

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
por: Tang, Fei, et al.
Publicado: (2018)

TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion
por: Sharma, Naveen, et al.
Publicado: (2019)

Cooperative Roles of CTLA-4 and Regulatory T Cells in Tolerance to an Islet Cell Antigen
por: Eggena, Mark P., et al.
Publicado: (2004)

Sub-lethal signals in the mitochondrial apoptosis apparatus: pernicious by-product or physiological event?
por: Häcker, Georg, et al.
Publicado: (2022)

Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
por: Lühder, Fred, et al.
Publicado: (1998)

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
por: Soldevilla, Mario Martínez, et al.
Publicado: (2019)

Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
por: Hancock, Wayne W., et al.
Publicado: (2000)

Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
por: Shi, Yaoyao, et al.
Publicado: (2020)

Plaque-associated myeloid cells derive from resident microglia in an Alzheimer’s disease model
por: Reed-Geaghan, Erin G., et al.
Publicado: (2020)

THYMUS-DEPENDENT LYMPHOCYTES IN TISSUE SECTIONS OF REJECTING RAT RENAL ALLOGRAFTS
por: Balch, C. M., et al.
Publicado: (1973)

Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection
por: Hancock, Wayne W., et al.
Publicado: (2001)

Muc5ac: a critical component mediating the rejection of enteric nematodes
por: Hasnain, Sumaira Z., et al.
Publicado: (2011)

Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8(+) T cell immunity to reject ‘cold’ tumors
por: Semmrich, Monika, et al.
Publicado: (2022)

Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production
por: Curran, Michael A., et al.
Publicado: (2011)

B7-1 or B7-2 Is Required to Produce the Lymphoproliferative Phenotype in Mice Lacking Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4)
por: Mandelbrot, Didier A., et al.
Publicado: (1999)

Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity
por: Weber, Felix C., et al.
Publicado: (2015)

Sex steroid blockade enhances thymopoiesis by modulating Notch signaling
por: Velardi, Enrico, et al.
Publicado: (2014)

Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer
por: Hermanova, Ivana, et al.
Publicado: (2020)

Bone Marrow Allograft Rejection Mediated by a Novel Murine NK Receptor, NKG2I
por: Koike, Junzo, et al.
Publicado: (2004)

CTLA-4 blockade: therapeutic potential in cancer treatments
por: Tarhini, Ahmad A, et al.
Publicado: (2010)

Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Can Regulate Dendritic Cell–induced Activation and Cytotoxicity of CD8(+) T Cells Independently of CD4(+)T Cell Help
por: McCoy, Kathy D., et al.
Publicado: (1999)

Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
por: Ju, Fei, et al.
Publicado: (2022)

Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance
por: Khan, Imran S., et al.
Publicado: (2014)

IL-9 as a mediator of Th17-driven inflammatory disease
por: Nowak, Elizabeth C., et al.
Publicado: (2009)

Prognostic and Predictive Biomarkers in Gliomas
por: Śledzińska, Paulina, et al.
Publicado: (2021)

Inflammatory Cytokine Profiles During Exercise in Obese, Diabetic, and Healthy Children
por: Galassetti, Pietro R., et al.
Publicado: (2011)

Complementary and Alternative Medicine in Children with Type 1 Diabetes Mellitus
por: Haliloglu, Belma, et al.
Publicado: (2011)

3M Syndrome: A Report of Four Cases in Two Families
por: Güven, Ayla, et al.
Publicado: (2011)

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)

Protective Immunity to Nematode Infection Is Induced by CTLA-4 Blockade
por: McCoy, Kathy, et al.
Publicado: (1997)

S43. Dendritic cell vaccination combined with CTLA4 blockade
por: Thielemans, K, et al.
Publicado: (2014)

CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic
por: Callahan, Margaret K., et al.
Publicado: (2015)

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
por: Du, Xuexiang, et al.
Publicado: (2018)

Radiotherapy enhances responses of lung cancer to CTLA-4 blockade
por: Wilkins, Anna, et al.
Publicado: (2019)

Radiotherapy induces responses of lung cancer to CTLA-4 blockade
por: Formenti, Silvia C., et al.
Publicado: (2018)

PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
por: Ali, Lestat R., et al.
Publicado: (2023)

IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection
por: Brooks, David G., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ipkocrukfln2pe80464ard7jq0